• Home

  • About Us

    • Corporate Profile

    • Milestones

    • Investment Partners

    • Corporate News

  • Products

    • Technological Innovation

    • Product Description

    • Guideline & Consensus

  • Sustainalibity

    • Corporate Values

    • Investor Relations

    • Discipline Development

  • Join Us

    • Join Us

  • Contact Us

  • Language

    • 简体中文

    • English

  • Home page

Radiotherapy Protective Hydrogels

Key words:

Products News

Products

News

RuiNing RuiXun | RuiNing Bio’s “Embolization Hydrogel” has been awarded the “2026 Outstanding Product Innovation Award” at the 15th CFS Financial Summit.

The second session of the “Injectable Absorbable Isolation Hydrogel Training Course” at the Tumor Center of Tongji Hospital, Huazhong University of Science and Technology, has concluded successfully.

New progress in deepening Shanghai–Xinjiang medical cooperation: Xinjiang’s first case of precision radiotherapy for prostate cancer assisted by Respacio® has been successfully performed.

The “Absorbable Isolation Hydrogel Injection Training Course” concluded successfully at the Oncology Center of Tongji Hospital, affiliated with Huazhong University of Science and Technology.

The inauguration ceremony of the Fudan–RuiNing Bio–ZuQuan “Future Intelligent Hydrogel Industry–University Joint Laboratory” was held successfully.

Respacio® isolation gel from Ruining Bio has been deployed for its first clinical use in cervical cancer patients at Wuhan Union Hospital.

Contact Us
Telephone: 021-51592768
E-mail: cs@reunionmed.com

Address: Floor 2, Building 7, 1630 Yecheng Road, Jiading District, Shanghai

Scan QR Code

Copyright©2024 Shanghai Reunion Biotechnology Co., Ltd.  

Powered by www.300.cn  SEO  

Business License